Australia markets closed

Lumos Pharma, Inc. (LUMO)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
2.8000+0.1100 (+4.09%)
At close: 04:00PM EDT
2.8300 +0.03 (+1.07%)
After hours: 04:44PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-34,034
-34,034
-31,062
-30,430
-5,663
Depreciation & amortisation
44
44
49
217
584
Deferred income taxes
-
-
-
0
-9,500
Stock-based compensation
2,322
2,322
2,320
2,879
1,074
Change in working capital
965
965
2,096
-2,314
-3,618
Other working capital
-31,095
-31,095
-26,644
-29,678
-23,027
Other non-cash items
-392
-392
-26
-
426
Net cash provided by operating activities
-31,095
-31,095
-26,623
-29,648
-22,997
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-21
-30
-30
Purchases of investments
-7,378
-7,378
-11,337
0
-
Sales/maturities of investments
18,120
18,120
0
-
-
Other investing activities
-
-
-
26,000
-
Net cash used for investing activities
10,742
10,742
-11,358
25,970
116,649
Cash flows from financing activities
Debt repayment
-
-
-
0
-27
Common stock issued
725
725
0
-
-
Common stock repurchased
-1,310
-1,310
-675
0
-
Other financing activities
-26
-26
-235
-262
-38
Net cash used provided by (used for) financing activities
-576
-576
-821
-192
75
Net change in cash
-20,929
-20,929
-38,802
-3,870
93,727
Cash at beginning of period
56,007
56,007
94,809
98,679
4,952
Cash at end of period
35,078
35,078
56,007
94,809
98,679
Free cash flow
Operating cash flow
-31,095
-31,095
-26,623
-29,648
-22,997
Capital expenditure
-
-
-21
-30
-30
Free cash flow
-31,095
-31,095
-26,644
-29,678
-23,027